Pharma Watch

Hello Eye Drops, Goodbye Glasses

Beginning around the age of 40, most adults have difficulty with near vision, and many find the need to use reading glasses. In October 2021, the US FDA granted approval for the use of Allergan’s eye drop, Vuity (pilocarpine HCl ophthalmic solution) 1.25%, which could eliminate the need for reading …

Read More »

The Situation of Community Pharmacies in Nepal

Pharmacies opened on a community level to cater to the medication needs of the people living in the nearby area are called community pharmacies. A community pharmacy (aushadhi pasal) is often referred to as a medical shop or chemist store or retail pharmacy in Nepal. In a developing nation like …

Read More »

Nootropics: Smart Drugs

Nootropics is a class of substances that can boost brain performance, and so are sometimes called cognition/memory enhancers. Prescription nootropics have stimulant effects and can offset symptoms of medical conditions like attention deficit hyperactivity disorder (ADHD), Alzheimer’s, or narcolepsy. Nonprescription substances like caffeine and creatine, which can enhance brain performance …

Read More »

New drug approvals recommended by European Medicines Agency

Roche’s Phesgo (pertuzumab/trastuzumab) is one of the half dozen medicines that the European Medicines Agency’s human medicines committee (CHMP) has recommended for approval at its November 2020 meeting. Phesgo has been endorsed as a treatment for early and metastatic breast cancer. Administered as a subcutaneous, fixed-dose combination of pertuzumab and …

Read More »

No benefit of four drugs for COVID patients, says WHO

The ongoing World Health Organization (WHO) Solidarity Trial of hydroxychloroquine, remdesivir, lopinavir, or interferon-beta-1a for the treatment of COVID-19 were found not to prevent in-hospital death, reduce need for ventilation, or shorten duration of hospitalization. The results have been published in the New England Journal of Medicine. The open-label study …

Read More »

Molnupiravir Suppresses SARS-CoV-2 Transmission Quickly

Researchers at the Institute for Biomedical Sciences, Georgia State University, have discovered that a new antiviral drug, Molnupiravir (MK-4482/EIDD-2801), completely suppresses SARS-CoV-2 transmission within 24 hours. The drug was originally found to be potent against influenza viruses. According to research team leader Dr. Richard Plemper, it is the first orally …

Read More »

Rapid Reversal of Age-related Mental Decline

A recent study has demonstrated that an experimental drug named ISRIB (integrated stress response inhibitor) rapidly restored youthful cognitive abilities in aged mice. The researchers said that ISRIB’s extremely rapid effects showed that an important component of age-related cognitive loss could be caused by reversible physiological “blockage”, rather than more …

Read More »
Sahifa Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.